Anavex Life Sciences Corp (AVXL)

[attilathehunt]

Reyeton

You stated"The next phase of the trial could then narrow down the participants in the upcoming trial, to individuals with a similar profile to the 6 super responders."

If that is the case, then would you think A2-73 would be tweaked to benefit other profiles or is that where A3-71 comes into the picture? If so, then that might explain the elevated prominence of A3-71 at the last conference.

In any event things are looking up.